manifestations due to arterial occlusion or parenchymal bleeding from the pathological vascular network. He suffered from arterial hypertension and type II diabetes mellitus, which were well controlled with medical treatment. The magnetic resonance imaging (MRI) scan showed a small ischemic lesion of the genu of the internal capsule with blood suffusion and mild intraventricular hemorrhage. In addition, a bilateral vascular malformation was suspected in the anterior part of the circle of Willis (Figure 1 (a) and (b)). Angiography showed a severe stenosis of the internal carotid arteries as well as the A1 of the anterior cerebral artery and M1 of the middle cerebral artery (MCA). Bilaterally, A1 and M1 appeared to be connected by a fine arterial network, localized at the base of the brain. A pseudoaneurysm was detected on the network between left A1 and M1 (Figure 1(c) and (d)), which could be a source of the bleeding observed on the MRI images. Considering the clinical and imaging findings as well as the absence of any sign of vasculitis, cancer or ischemic manifestation, the patient was diagnosed with MMD.
As there is no specific medical treatment for this condition, the patient was referred to the Neurosurgery department and underwent a left bypass between the superficial temporal artery (STA) and MCA, in order to restore vascularization of the circle of Willis and to treat the pseudoaneurysm. Follow-up computed tomography (CT) angiography showed patency of the anastomosis and a good revascularization of the left MCA. Six months after surgery, the patient was clinically stable and his symptoms have disappeared.
Different patterns of clinical onset have been reported, but typically ischemic symptoms are the first to appear in children, while in adults intracranial hemorrhage occurs because of rupture of the abnormal vascular network. 1 The onset of MMD symptoms mainly occurs in the first decade of life in patients with sickle cell disease, and less frequently in the third decade of life. 2 The reported incidence of MMD is 0.086 per 100,000 Caucasian inhabitants, which is 10 times lower than the incidence in inhabitants of Far Asian countries, 0.54 per 100,000. 2 MMD is a chronic occlusive cerebrovascular disorder characterized by bilateral stenosis of the distal portion of the internal carotid arteries associated with an abnormal vascular network at the base of the brain.
Patients with unilateral findings or those with bilateral lesions but associated with systemic disorders (such as trisomy 21, autoimmune disease or neurofibromatosis) are defined as having moyamoya syndrome (MMS). 2, 3 In our patient, all diagnostic criteria were present, with no other signs of systemic disease. The pathogenesis of MMD is still unclear. Studies in family cases suggest a genetic susceptibility in developing MMD, especially linked to the sole locus at 17q25 (related to ring finger protein 213), even though other loci seem to be involved (i.e. those related to vascular endothelial growth factor, metalloprotease and smooth muscle cells). 4 MMD in Caucasian older patients is a very rare condition that clinicians and radiologists working in Western countries will hardly consider in their differential diagnoses. However, a prompt diagnosis and a focused treatment are important for patient outcome. 
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